The Netherlands: Oxitope Pharma launches with seed financing from Forbion

A new Dutch biotech company has been formed. Oxitope Pharma, which focuses on Oxidation Specific Epitopes (OSEs) as new targets for drug discovery, was founded in March 2020 and seed funded by Forbion, the European life sciences VC firm. Forbion founded Oxitope based on the potential of high-quality science from University of California San Diego…

You must be a HMI Subscriber to view this content.

Subscribe Now »